Curative Biotechnology Inc (CUBT)

Curative Biotechnology Inc (CUBT) is a Biotechnology company in the Healthcare sector listed on the NYSE MKT.

As of Oct 23, 2026: market cap $8.4M; returns 1 day -2.0%, 1 week -23.0%, 1 year -33.3%.

Curative Biotechnology Inc. (CUBT) is a development-stage biotechnology company that does not currently generate revenue. Its business model is centered on identifying, in-licensing, and developing therapeutic drug candidates, with a primary focus on rare diseases that may qualify for accelerated regulatory pathways.

Groups CUBT belongs to

• Biotechnology
• Recent Reverse Splits
• Healthcare
• Clinical Stage Biotech
• Clinical Stage
• Rare Diseases
• Drug Discovery
• Oncology
• Infectious Diseases
• Ophthalmology
• Antibody-Drug Conjugates

CUBT financial model: income statement, cash flow and balance sheet